CIBC Asset Management Inc Boosts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

CIBC Asset Management Inc increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 189,822 shares of the medical equipment provider's stock after buying an additional 9,524 shares during the quarter. CIBC Asset Management Inc owned about 0.05% of Intuitive Surgical worth $93,254,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of the stock. International Assets Investment Management LLC grew its stake in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock worth $535,788,000 after purchasing an additional 1,088,415 shares in the last quarter. Capital Research Global Investors acquired a new position in Intuitive Surgical in the first quarter worth $374,390,000. Vanguard Group Inc. increased its stake in Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider's stock valued at $12,319,358,000 after purchasing an additional 493,126 shares during the last quarter. Strategic Financial Concepts LLC raised its holdings in shares of Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider's stock worth $1,184,000 after purchasing an additional 265,461 shares during the period. Finally, GQG Partners LLC bought a new position in shares of Intuitive Surgical in the 1st quarter worth about $99,523,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling

In related news, General Counsel Gary Loeb sold 300 shares of the company's stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares in the company, valued at approximately $757,625. This represents a 15.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 396 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $486.88, for a total value of $192,804.48. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,680,761.28. This trade represents a 6.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 91,178 shares of company stock worth $45,897,071 in the last ninety days. Corporate insiders own 0.90% of the company's stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded down $9.61 during mid-day trading on Friday, hitting $528.19. 851,410 shares of the company's stock traded hands, compared to its average volume of 1,458,598. The firm has a 50 day simple moving average of $498.17 and a two-hundred day simple moving average of $456.22. The stock has a market cap of $188.13 billion, a price-to-earnings ratio of 85.96, a P/E/G ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $295.02 and a fifty-two week high of $544.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on ISRG shares. BTIG Research set a $535.00 price target on Intuitive Surgical in a research report on Friday, October 18th. Piper Sandler reiterated an "overweight" rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer reaffirmed a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Mizuho lifted their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a "buy" rating in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.